These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31453219)

  • 1. CRISPR Explorer: A fast and intuitive tool for designing guide RNA for genome editing.
    Chen K; Jin Y; Lin YC
    J Biol Methods; 2016; 3(4):e56. PubMed ID: 31453219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Genome Editing Using CRISPR/Cas9.
    Ding Y; Li H; Chen LL; Xie K
    Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-guided genome editing in plants using a CRISPR-Cas system.
    Xie K; Yang Y
    Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 6. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-DT: designing gRNAs for the CRISPR-Cpf1 system with improved target efficiency and specificity.
    Zhu H; Liang C
    Bioinformatics; 2019 Aug; 35(16):2783-2789. PubMed ID: 30615056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized guide RNA structure for genome editing via Cas9.
    Xu J; Lian W; Jia Y; Li L; Huang Z
    Oncotarget; 2017 Nov; 8(55):94166-94171. PubMed ID: 29212218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EuPaGDT: a web tool tailored to design CRISPR guide RNAs for eukaryotic pathogens.
    Peng D; Tarleton R
    Microb Genom; 2015 Oct; 1(4):e000033. PubMed ID: 28348817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BEtarget: A versatile web-based tool to design guide RNAs for base editing in plants.
    Xie X; Li F; Tan X; Zeng D; Liu W; Zeng W; Zhu Q; Liu YG
    Comput Struct Biotechnol J; 2022; 20():4009-4014. PubMed ID: 35983232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
    Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells.
    Allen D; Rosenberg M; Hendel A
    Front Genome Ed; 2020; 2():617910. PubMed ID: 34713240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic Improvement of CRISPR/Cas9 Editing in
    Ng H; Dean N
    mSphere; 2017; 2(2):. PubMed ID: 28435892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
    Liu G; Li J; Godwin ID
    Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated targeted mutagenesis in Nicotiana tabacum.
    Gao J; Wang G; Ma S; Xie X; Wu X; Zhang X; Wu Y; Zhao P; Xia Q
    Plant Mol Biol; 2015 Jan; 87(1-2):99-110. PubMed ID: 25344637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPRedict: a CRISPR-Cas9 web tool for interpretable efficiency predictions.
    Konstantakos V; Nentidis A; Krithara A; Paliouras G
    Nucleic Acids Res; 2022 Jul; 50(W1):W191-W198. PubMed ID: 35670672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.